Watchlist Price Alert

Cardinal Health Inc. (CAH)

NYSE: CAH · Real-Time Price · USD

151.68

2.15 (1.44%)

At close: May 05, 2025, 3:59 PM

151.49

-0.13%

Pre-market: May 06, 2025, 06:36 AM EDT

1.44% (1D)

Bid	150
Market Cap	36.64B
Revenue (ttm)	222.29B
Net Income (ttm)	1.56B
EPS (ttm)	6.38
PE Ratio (ttm)	23.77
Forward PE	16.67
Analyst	Buy

Ask	153
Volume	1,999,363
Avg. Volume (20D)	2,598,176
Open	150.69
Previous Close	149.53
Day's Range	150.21 - 152.98
52-Week Range	93.17 - 152.98
Beta	0.63

About CAH

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and gen...

[Read more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Aug 4, 1983

Employees 47,922

Stock Exchange NYSE

Ticker Symbol CAH

Website https://www.cardinalhealth.com

Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for CAH stock is "Buy." The 12-month stock price forecast is $144.5, which is a decrease of -4.73% from the latest price.

Stock Forecasts

Earnings Surprise

Cardinal Health has released their quartely earnings on May 1, 2025:

Revenue of $54.88B misses estimates by $472M, with 0.02% YoY growth.

EPS of 2.35 exceeds estimates by 0.18, with 12.44% YoY growth.

Why Price Moved

6 months ago

+7.01%

Cardinal Health shares are trading higher after th... Unlock content with Pro Subscription

8 months ago

+3.68%

Cardinal Health shares are trading higher after the company reported strong Q4 results and raised its 2025 outlook.

News

23 hours ago · zacks.com

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 days ago · seekingalpha.com

Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May

This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Industrial engineering company Parker-Hannifin announced i...

3 days ago · zacks.com

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

4 days ago · benzinga.com

Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks

Cardinal Health Inc. CAH on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17.

5 days ago · seekingalpha.com

Cardinal Health, Inc. (CAH) Q3 2025 Earnings Call Transcript

Cardinal Health, Inc. (NYSE:CAH ) Q3 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aar...

5 days ago · zacks.com

CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains

Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

5 days ago · zacks.com

Cardinal (CAH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

5 days ago · zacks.com

Cardinal Health (CAH) Beats Q3 Earnings Estimates

Cardinal Health (CAH) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.08 per share a year ago.

5 days ago · reuters.com

Cardinal Health lifts full-year profit forecast again on specialty medicine sales

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.

6 days ago · zacks.com

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.

Load More News